Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07639333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA

Study acronym: GRACE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Sep 2026 to Sep 11, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 2 of 4 entries
  2. Recruitment opened
    • Start date: Jul 2026 to Sep 2026
    • Site details revised
    v3
  3. Study title shortened, about 3 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage
Trial Details
NCT Number NCT07639333
Lead Sponsor Rennes University Hospital
Conditions
(from sponsor)		 Miscarriage in First Trimester, Prenatal Genetic Diagnosis
Related terms Abortion, Spontaneous
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov